As More Indian Companies Dive Into Biosimilars, Will Success In Generic Drugs Repeat?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - In August, when leading Indian drug maker Dr. Reddy's Labs launched Cresp, a biosimilar brand of Amgen's darbepoetin alfa Aranesp, G.V.Prasad, Reddy's chief executive officer exulted at a media briefing that his company may well be on course to becoming the largest biologics player in the world in a few years, next only to Swiss giant Roche